Metformin, Independent of AMPK, Inhibits mTORC1 In a Rag GTPase-Dependent Manner

By Adem Kalender, A. Selvaraj, S. Kim, P. Gulati, Sophie Br lé, B. Viollet, Bruce E. Kemp, N. Bardeesy, P. Dennis, John J. Schlager and 3 more. Cell Metabolism, 2010

894 citations recorded by the source corpus.

Dysfunctional mTORC1 signaling is associated with a number of human pathologies owing to its central role in controlling cell growth, proliferation, and metabolism. Regulation of mTORC1 is achieved by the integration of multiple inputs, including those of mitogens, nutrients, and energy. It is thought that agents that increase the cellular AMP/ATP ratio, such as the anti-diabetic biguanides metformin and phenformin, inhibit mTORC1 through AMPK activation of TSC1/2-dependent or -independent mechanisms. Unexpectedly, we found that biguanides inhibit mTORC1 signaling, not only in the absence of TSC1/2, but also in the absence of AMPK. Consistent with these observations, in two distinct pre-clinical models of cancer and diabetes, metformin acts to suppress mTORC1 signaling in an AMPK-independent manner. We found that the ability of biguanides to inhibit mTORC1 activation and signaling is, instead, dependent on the Rag GTPases.

Subfields: Molecular Biology, Surgery

View Paper: https://www.semanticscholar.org/paper/4ba4f419f2bb0a7276afd0c645d5247669a4d238

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

  1. David M. Sabatini
  2. R. A. Saxton
  3. Timothy R. Peterson
  4. Shomit Sengupta
  5. Rajiv K. Tonk
  6. Vivek Panwar
  7. Manini Bhatt
  8. Shinjinee Sengupta

In Surgery

  1. David M. Sabatini
  2. Liangyou Rui

Citations in the corpus